Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/12/2010 | WO2010090611A2 Taste and odor masked pharmaceutical compositions with high bioavailability |
08/12/2010 | WO2010090596A1 Hollow silica particle with a polymer thereon |
08/12/2010 | WO2010090546A1 Composition of amino acids for sublingual applying for enhanced skin integument repigmentation in vitiligo and method of its administration |
08/12/2010 | WO2010090508A1 Natural colorant and methods thereof |
08/12/2010 | WO2010090502A2 External use composition containing cholecalciferol or its derivative for treating skin disorders |
08/12/2010 | WO2010090371A1 Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process |
08/12/2010 | WO2010090346A1 Film base for adhesive patch, and adhesive patch |
08/12/2010 | WO2010090222A1 Hb-egf-bound protein complex |
08/12/2010 | WO2010089775A2 Improved drug dosage form for controlled delivery of one or more pharmaceutically active agent |
08/12/2010 | WO2010089767A1 Dual release pharmaceutical suspension |
08/12/2010 | WO2010089674A1 Orosoluble and/or effervescent compositions containing at least a salt of s- adenosyl methionine (same) |
08/12/2010 | WO2010089672A1 Glp-1 analogues pharmaceutical compositions |
08/12/2010 | WO2010089617A2 Transdermal pharmaceutical preparations |
08/12/2010 | WO2010089522A1 Stable formulation of a therapeutic protein |
08/12/2010 | WO2010089492A1 Method for coating microspheres onto a flexible material |
08/12/2010 | WO2010089379A1 Method and means for producing tissues and tissues obtained |
08/12/2010 | WO2010089372A1 Pharmaceutical compositions comprising brivaracetam |
08/12/2010 | WO2010089361A2 Process for the preparation of a pharmaceutical composition comprising ezetimibe |
08/12/2010 | WO2010089330A1 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma |
08/12/2010 | WO2010089259A2 Sustained release composition containing quetiapine |
08/12/2010 | WO2010089132A1 Immediate release composition resistant to abuse by intake of alcohol |
08/12/2010 | WO2010089128A2 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
08/12/2010 | WO2010089105A2 Moisture-activated granulation process |
08/12/2010 | WO2010089104A2 Resveratrol compositions |
08/12/2010 | WO2010089078A1 Buccal application system comprising 17α-estradiol |
08/12/2010 | WO2010089046A1 In situ preparations forming bonding gel, in particular for topical application to moistened skin/mucous membranes |
08/12/2010 | WO2010088924A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
08/12/2010 | WO2010088911A1 Pharmaceutical compositions resistant to abuse |
08/12/2010 | WO2010088827A1 Novel uses of huperzine a and ophthalmic preparations thereof |
08/12/2010 | WO2010088786A1 Herbal composition having cox-2 and immune activities and preparation method thereof |
08/12/2010 | WO2010068688A3 System and method for the delivery of a sanitizing foam |
08/12/2010 | WO2010065784A3 Methods, devices, and compositions for dermal filling |
08/12/2010 | WO2010060529A8 Microparticles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone |
08/12/2010 | WO2010055252A3 Plant-based granules |
08/12/2010 | WO2010052491A3 Collar protector |
08/12/2010 | WO2010050787A3 Encapsulated functional fine particle composition capable of spraying and preparation method thereof |
08/12/2010 | WO2010046865A3 Ophthalmic administration of a composition including brimonidine as a mist |
08/12/2010 | WO2010040345A3 Ecdysone derivatives and the use thereof |
08/12/2010 | WO2010036975A3 Dipyridamole and acetylsalicylic acid formulations and process for preparing same |
08/12/2010 | WO2010036721A3 Systems, methods and devices for using a flowable medium for distending a hollow organ |
08/12/2010 | WO2010015400A3 Injectable taxane pharmaceutical composition |
08/12/2010 | WO2010001413A3 Sustained release pharmaceutical compositions comprising quetiapine |
08/12/2010 | WO2009134371A3 Composite lacrimal insert and related methods |
08/12/2010 | WO2009117410A8 Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques |
08/12/2010 | WO2009102355A3 Adhesive patch systems and methods |
08/12/2010 | WO2009076270A3 Microstructured antimicrobial film |
08/12/2010 | WO2009075582A3 Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids |
08/12/2010 | WO2009012303A3 Therapeutic stable nanoparticles |
08/12/2010 | US20100204448 Method and carrier complexes for delivering molecules to cells |
08/12/2010 | US20100204147 Methods For Delivering Thymosin Beta 4, Analogues, Isoforms and Other Derivatives |
08/12/2010 | US20100203171 is generated and delivered simultaneously using a syringe based device; comprises a sclerosant liquid, polidocanol solution, and gas N2, xenon; by inter alia causing a localised inflammatory reaction, favor the elimination of varicose veins; low density; half-life |
08/12/2010 | US20100203153 Sustained-release nanoparticle compositions and methods using the same |
08/12/2010 | US20100203152 Mixed metal compounds used as antacids |
08/12/2010 | US20100203151 Microspheres having core/shell structure |
08/12/2010 | US20100203150 Novel amphiphilic copolymers and fabrication method thereof |
08/12/2010 | US20100203149 Nanoparticles for Cytoplasmic Drug Delivery to Cancer Cells |
08/12/2010 | US20100203148 Encapsulation and Controlled Release of Small Molecules for Intracellular Delivery Using Thermally Responsive Nanocapsules |
08/12/2010 | US20100203147 Viruses for the Treatment of Cellular Proliferative Disorders |
08/12/2010 | US20100203146 Intermittent dosing strategy for treating rheumatoid arthritis |
08/12/2010 | US20100203145 Continuous process for microspheres production by using expanded fluids |
08/12/2010 | US20100203144 Immobilized Metallic Nanoparticles as Unique Materials for Therapeutic and Biosensor Applications |
08/12/2010 | US20100203143 Systems and methods for nanomagnetic actuation of molecular cell signaling |
08/12/2010 | US20100203142 Amphiphilic compound assisted nanoparticles for targeted delivery |
08/12/2010 | US20100203141 Stimuli-responsive low solubility hydrogel copolymers of n-isopropyl acrylamide and synthesis method |
08/12/2010 | US20100203140 Methods, compositions, and kits for organ protection during systemic anticancer therapy |
08/12/2010 | US20100203139 Nanoemulsion therapeutic compositions and methods of using the same |
08/12/2010 | US20100203138 Controlled Release Composition Comprising a Recombinant Gelatin |
08/12/2010 | US20100203137 Formulation of meningitis vaccines |
08/12/2010 | US20100203136 METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (Hcg) VACCINE FOR LONG-ACTING ANTIBODY PROTECTION |
08/12/2010 | US20100203135 Skin Equivalent Culture |
08/12/2010 | US20100203134 Spheroids and multiparticulate tablets comprising them |
08/12/2010 | US20100203133 High drug load tablet |
08/12/2010 | US20100203132 Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and AT1 Receptor Antagonists |
08/12/2010 | US20100203131 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine |
08/12/2010 | US20100203130 Pharmaceutical compositions resistant to abuse |
08/12/2010 | US20100203129 Controlled release formulations with continuous efficacy |
08/12/2010 | US20100203128 Bupropion hydrobromide and therapeutic applications |
08/12/2010 | US20100203127 Large dose ribavirin formulations |
08/12/2010 | US20100203126 Multilayered vitamin complex tablet containing ubidecarenone |
08/12/2010 | US20100203125 Synergistic antibacterial formulation and a method of making the same |
08/12/2010 | US20100203124 Kappa-2 Carrageenan Composition and Products Made Therefrom |
08/12/2010 | US20100203123 Methods for improving cognitive function and decreasing heart rate |
08/12/2010 | US20100203122 Delivery System for Remote Treatment of an Animal |
08/12/2010 | US20100203121 Formation of nanometric core-shell particles having a metal oxide shell |
08/12/2010 | US20100203120 Pharmaceutical cyclosporin compositions |
08/12/2010 | US20100203119 Pharmaceutical treatment process using chitosan or derivative thereof |
08/12/2010 | US20100203117 Anti-adipogenic compositions containing piper betle and dolichos biflorus |
08/12/2010 | US20100203116 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
08/12/2010 | US20100203115 Organic-inorganic hybrid material for the storage and release of active principles |
08/12/2010 | US20100203114 Micelle encapsulation of therapeutic agents |
08/12/2010 | US20100203113 Wnt signalling inhibitors, and methods for making and using them |
08/12/2010 | US20100203112 Composition of cationic phospholipid nanoparticles for effective delivery of nucleic acids |
08/12/2010 | US20100203111 G-substrate for the treatment and prevention of parkinson's disease |
08/12/2010 | US20100203110 Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production |
08/12/2010 | US20100203109 Methods and Compositions for Treating Melanoma |
08/12/2010 | US20100203108 Patch and patch preparation |
08/12/2010 | US20100203107 Methods of Administering a Dermatological Agent to a Subject |
08/12/2010 | US20100203105 Method for administering insulin to the buccal region |
08/12/2010 | US20100203104 Delivery system for risperidone |
08/12/2010 | US20100203103 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues |